BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33093529)

  • 1. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma.
    Dankert JT; Wiesehöfer M; Wach S; Czyrnik ED; Wennemuth G
    Sci Rep; 2020 Oct; 10(1):18022. PubMed ID: 33093529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
    Zheng C; Guo K; Chen B; Wen Y; Xu Y
    Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
    Du C; Lv C; Feng Y; Yu S
    J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells.
    Dankert JT; Wiesehöfer M; Czyrnik ED; Singer BB; von Ostau N; Wennemuth G
    PLoS One; 2018; 13(7):e0200472. PubMed ID: 30001402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells.
    Hu B; Jin X; Wang J
    Oncol Res; 2018 Aug; 26(7):1093-1102. PubMed ID: 29321092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
    Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
    Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.
    Zhao S; Jie C; Xu P; Diao Y
    J Cell Biochem; 2020 Jan; 121(1):482-488. PubMed ID: 31310382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑198 suppresses prostate tumorigenesis by targeting MIB1.
    Ray J; Hoey C; Huang X; Jeon J; Taeb S; Downes MR; Boutros PC; Liu SK
    Oncol Rep; 2019 Sep; 42(3):1047-1056. PubMed ID: 31322262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.
    Carvalheira G; Nozima BH; Cerutti JM
    Oncotarget; 2015 Sep; 6(29):28357-70. PubMed ID: 26317551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles for the RNA-binding protein Staufen1 in prostate cancer.
    Marcellus KA; Crawford Parks TE; Almasi S; Jasmin BJ
    BMC Cancer; 2021 Feb; 21(1):120. PubMed ID: 33541283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
    Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
    Yang ZG; Ma XD; He ZH; Guo YX
    Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.
    Hasegawa T; Glavich GJ; Pahuski M; Short A; Semmes OJ; Yang L; Galkin V; Drake R; Esquela-Kerscher A
    Mol Cancer Res; 2018 Apr; 16(4):669-681. PubMed ID: 29330297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.